Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet

v2.4.0.8
Balance Sheet (USD $)
Sep. 30, 2013
Dec. 31, 2012
Current Assets:    
Cash and cash equivalents $ 14,871,000 $ 13,486,543
Marketable securities (note 3) 100,000 100,000
Prepaid expenses and other current assets (note 4) 523,117 188,808
Total Current Assets 15,494,117 13,775,351
Restricted Cash Equivalents (note 16) 509,179 1,091,801
Equipment, Net (note 6) 70,419 52,156
Total Assets 16,073,715 14,919,308
Current Liabilities:    
Accounts payable and accrued expenses (note 7) 750,242 851,837
Deferred Research and Development Arrangement (note 8) 1,165,429 1,626,000
Other Liabilities (note 9) 114,588 65,417
Warrant Liabilities (note 13) 4,192,216 2,842,065
Total Liabilities 6,222,475 5,385,319
Commitments and Contingencies (note 16)      
Stockholders' Equity (note 11):    
Preferred stock, par value $0.0001, 100,000,000 authorized shares, none issued and outstanding 0 0
Common stock, par value $0.0001, 500,000,000 authorized shares, 134,457,144 and 119,443,194 issued and 134,442,939 and 119,428,989 oustanding 13,446 11,944
Additional paid-in capital 79,957,246 72,861,738
Accumulated deficit during the development stage (70,091,042) (63,311,283)
Treasury stock, 14,205 shares, at cost (28,410) (28,410)
Total Stockholders' Equity 9,851,240 9,533,989
Total Liabilities and Stockholders' Equity $ 16,073,715 $ 14,919,308